Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report

Miriam Rigoldi1, Caterina Mele1, Matteo Breno1

  • 1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Ranica, Italy.

Nephron
|September 18, 2024
PubMed

Insights

Lysinuric protein intolerance (LPI) is a rare metabolic disorder. This case highlights LPI presenting as chronic kidney disease in an adult, emphasizing subtle symptoms for diagnosis.

Area of Science:

  • Biochemistry
  • Genetics
  • Nephrology

Background:

  • Lysinuric protein intolerance (LPI) is a rare, multisystemic inborn error of metabolism.
  • It typically presents in childhood with growth failure and gastrointestinal/neurological issues due to urea cycle dysfunction.

Observation:

  • A 40-year-old woman with chronic kidney disease was diagnosed with LPI.
  • Her diagnosis was delayed due to subtle, non-critical symptoms including aversion to protein, drowsiness, splenomegaly, thrombocytopenia, elevated LDH, hyperferritinemia, and hypertriglyceridemia.

Findings:

  • Biochemical and genetic investigations confirmed LPI in the patient.
  • The case illustrates LPI's variable expressivity and potential for late diagnosis.

Implications:

  • Nephrologists should consider LPI in patients with unexplained chronic kidney disease, proteinuria, or tubular dysfunction.
  • Key indicators include growth failure, urea cycle impairment symptoms, hepatosplenomegaly, and specific laboratory abnormalities.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
823
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
145
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K